With the right announcement this could easily see 100-200% gains. That would still only put this at a market cap of about $9m.
Patience needed. Even the equiv. pre-consol price is only 1.4c so that is an obvious short-term target. Hate to think what the average price of long-term holders is tho.
- Forums
- ASX - By Stock
- SBN
- Ann: Sun Biomedical Completes First Phase of Oraline Testing
Ann: Sun Biomedical Completes First Phase of Oraline Testing, page-13
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online